Compare Mesoblast Limited (MESO) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Toyota Motor Corp — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Toyota Motor Corp trades at $189.04 (market cap $221.79B). The key difference: Toyota Motor Corp is far larger — about 100.4× Mesoblast Limited's market cap, and Toyota Motor Corp pays a 3.3% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | TM | |
|---|---|---|
Market Cap | $2.21B | $221.79B |
Sector | Technology | Consumer Cyclical |
52-Week High | $20.96 | $248.29 |
52-Week Low | $12.88 | $166.50 |
Enterprise Value | $2.21B | $414.06B |
Dividend Yield | — | 3.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
